Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Muscular Atrophy × Olanzapine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Vomiting 3 Nausea 2 Anorexia 2 Weight Loss 1 Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Muscular Atrophy 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Gynecologic Cancer 1 Gliosarcoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Child Nutrition Disorders 1 Cachexia 1 Breast Neoplasms 1

Interventions

Standard of Care 1 Olanzapine 1 Enteral Nutrition 1 Electric Stimulation 1 Cyproheptadine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡